Posts Tagged ‘pharmaceuticals’

Medical roundup

Food and Drug Administration roundup

Medical roundup

  • “Judge Says He’s Had Enough Of Weeding Through Baseless Lawsuits, Threatens Sanctions” [Daniel Fisher; M. D. Georgia judge on vaginal mesh cases]
  • More on pricey regulated generics [Scott Gottlieb/WSJ, earlier on EpiPen, more on latter from Joel Zinberg/City Journal]
  • Feds ban pre-dispute arbitration agreements in nursing home care [McKnights]
  • How Ronald Reagan’s FDA responded to the AIDS crisis — and it’s probably not the story you’ve heard [Peter Huber, City Journal; see also from Carl Cannon in 2014]
  • FDA regs likely to winnow smaller, distinctive makers from the cigar business, recalling a Somerset Maugham story [James M. Patterson] Debunking the “Helena miracle,” once more: no link between local smoking bans and short-term drops in heart attacks [Jacob Sullum, earlier here and here]
  • “Ethicists make the case for bone marrow transplantation markets” [Ilya Somin]

Medical roundup

  • FDA to dental consumers: you can’t handle the tooth [New York Times via Alex Tabarrok]
  • “How lawyers scare people out of taking their meds” [Lisa Rickard (U.S. Chamber), Washington Post]
  • Lawsuits fail to bring improvements to nursing homes [ABA Journal]
  • Everything,” new Institute for Justice short film about costs of regulating bone marrow donation, has upcoming screenings in D.C. area, Breckinridge, Colo. and elsewhere;
  • Aetna pulls out of most ObamaCare exchanges, and the acrimony flies [WSJ editorial] “Did the Medicaid expansion limit labor force participation?” [Tomas Wind via Tyler Cowen]
  • Posting will be slower in coming weeks as I conduct my own in-person investigation of the state of America’s medical system. Thanks for bearing with me!

Medical roundup

  • “Here’s how lawmakers want to fix our kidney shortage” [Robert Gebelhoff, ideas of Sally Satel and others; Alex Tabarrok on Rep. Matt Cartwright (D-Pa.)’s proposed Organ Donor Clarification Act]
  • AMA: Lawyer ads stirring up pharmaceutical litigation are scaring viewers into going off needed medications [Jessica Karmasek, Forbes]
  • How does Cuba score such good infant health data? Fudging statistics, jailing truth-tellers helps [video, Free To Choose TV, “Dead Wrong” with Johan Norberg]
  • Per Swedish study, lottery winners do not get healthier after their windfalls. Some implications about health care and inequality? [Alex Tabarrok]
  • Really, AMA: declaring shootings a public health crisis at best a political stunt [Trevor Burrus]
  • Is ten years too long, Your Honor? “New York Lawmakers Push to Extend Deadline for Med-Mal Suits” [Insurance Journal]

Medical roundup

Feds overreach in prosecution of FedEx for failure to snoop

“Federal prosecutors have accused FedEx of knowingly shipping illegal drugs in interstate commerce and laundering money by merely doing its job: delivering packages (in this case, from online Internet pharmacies) to their intended recipients and getting paid for the service. …To avoid the very sort of ‘gotcha’ prosecution at issue here, Congress inserted exceptions for common carriers in each of the relevant statutes” authorizing shipment of prescription medications and controlled substances when done in the usual course of business.

While courts have generated no case law authoritatively interpreting these exemptions in the Controlled Substances Act (CSA) and the Food, Drug, & Cosmetic Act (FDCA), “the need to do so had never presented itself because no prosecutor had ever dared to bring such a dubious indictment in the previous 45 years of the CSA’s existence.” [Cory Andrews, Washington Legal Foundation; earlier (“Feds indict FedEx for not snooping into packages”)]

“New Hedge Fund Strategy: Dispute the Patent, Short the Stock”

Like a sports team getting to bet on its own game? “A well-known hedge-fund manager is taking a novel approach to making money: filing and publicizing patent challenges against pharmaceutical companies while also betting against their shares.” [WSJ; ten years ago on selling short, then suing] More: Bainbridge on an academic paper analyzing the effects when a litigant holds long or short positions in its opponent.

Medical roundup